The effects of single- and multiple-dose administration of bococizumab (RN316/PF-04950615), a humanized IgG2[Delta]a monoclonal antibody binding proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects treated with and without atorvastatin: Results from four phase I studies
Gumbiner, Barry, Joh, Tenshang, Liang, Hong, Wan, Hong, Levisetti, Matteo, Vana, Alicia M, Shelton, David L, gues, Philippe, Billotte, Stephan, Pons, Jaume, Baum, Charles M, Garzone, Pamela D
Published in Cardiovascular therapeutics (01.02.2018)
Published in Cardiovascular therapeutics (01.02.2018)
Get full text
Journal Article
The effects of single‐ and multiple‐dose administration of bococizumab (RN316/PF‐04950615), a humanized IgG2Δa monoclonal antibody binding proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects treated with and without atorvastatin: Results from four phase I studies
Gumbiner, Barry, Joh, Tenshang, Liang, Hong, Wan, Hong, Levisetti, Matteo, Vana, Alicia M., Shelton, David L., Forgues, Philippe, Billotte, Stephan, Pons, Jaume, Baum, Charles M., Garzone, Pamela D.
Published in Cardiovascular therapeutics (01.02.2018)
Published in Cardiovascular therapeutics (01.02.2018)
Get full text
Journal Article